Newsroom
Truveta news releases
Truveta and Alpine Immune Sciences announce strategic partnership to access Truveta’s community to accelerate recruitment to povetacicept clinical trials
Truveta’s 28 health system members provide over 16% of patient care in the United States. BELLEVUE and SEATTLE, Wash. – March 21, 2023 – Today, Truveta and Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced a strategic partnership to help accelerate clinical trial...
New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
Expanded de-identified social drivers of health data in Truveta Studio empower new health equity scenarios to study health disparities and improve patient care. BELLEVUE, Wash. – February 28, 2023 – Truveta announced the expansion of its de-identified data to include...
Truveta’s COVID-19 breakthrough infections research published in Vaccine
In a study of more than 1.2 million patients, new research shows the interaction effects of multiple comorbidities on the increased risk of COVID-19 breakthrough infections and hospitalizations. BELLEVUE, Wash. – February 23, 2023 – Today Truveta announced new...
New research: Preeclampsia-related heart failure disproportionately impacts Black mothers
Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women. BELLEVUE, Wash. – February 8, 2023 – Today Truveta announced new maternal heart health and health equity...
Truveta expands with three new US health system members
With 27 health system members, Truveta now includes de-identified patient journeys from all 50 US states. BELLEVUE, Wash. – January 24, 2023 – Three healthcare providers — HealthPartners, HonorHealth, and TriHealth — have joined Truveta, the company with a vision of...
Truveta Research shares new insights on RSV hospitalization trends
New Truveta Research monitoring report shows rates of RSV hospitalizations compared to previous years, part of new research capabilities in Truveta Studio for ongoing disease monitoring. BELLEVUE, Wash. – January 19, 2023 – Today, Truveta released new research...
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
New research published in Frontiers in Public Health shows racial disparities in COVID-19 hospitalization lengths of stay and access to treatments early in the pandemic. BELLEVUE, Wash. – January 19, 2023 – Today Truveta announced new COVID-19 health equity research...
Truveta Studio delivers the health data and analytics the world deserves now
First data and analytics solution to study patient care and outcomes now available BELLEVUE, Wash. – November 2, 2022 – Today, Truveta announced the availability of Truveta Studio, bringing together unprecedented health data and analytics for researchers to study...
Truveta announces collaboration with Boston Scientific to advance post-procedure patient insights and help address healthcare disparities
BELLEVUE, Wash. – September 27, 2022 –Today, Truveta announced a strategic collaborative agreement with Boston Scientific to improve long-term patient care and gain insights into healthcare disparities. Through this collaboration, Boston Scientific researchers will be...
